A study protocol for a double-blind randomised placebo-controlled trial evaluating the efficacy of carrageenan nasal and throat spray for COVID-19 prophylaxis —ICE-COVID

DiscussionThis is a single-centre, phase III, double-blind, randomised placebo-controlled clinical trial to assess whether carrageenan nasal and throat spray reduces the risk of development and severity of COVID-19. If proven effective, the self-administered prophylactic spray would have wider utility for key workers and the general population.Trial registrationNCT04590365;ClinicalTrials.gov NCT04590365. Registered on 19 October 2020.
Source: Trials - Category: Research Source Type: clinical trials